Da32 Life Science Tech Acquisition Corp Cl A (DALS)
Da32 Life Science Tech Acquisition Corp Cl A (DALS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2017 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 599 | -571 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1 | 0 | N/A | N/A | N/A |
| Other Working Capital | 1,207 | -387 | N/A | N/A | N/A |
| Other Operating Activity | -2,903 | -25 | 0 | 0 | 0 |
| Operating Cash Flow | $-1,096 | $-983 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | 0 | -200,000 | N/A | N/A | N/A |
| Investing Cash Flow | $0 | $-200,000 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 200 | N/A | N/A | N/A |
| Common Stock Issued | 0 | 206,525 | N/A | N/A | N/A |
| Other Financing Activity | -70 | -3,877 | 0 | 0 | 0 |
| Financing Cash Flow | $-70 | $202,848 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 1,865 | 0 | N/A | N/A | N/A |
| End Cash Position | 699 | 1,865 | N/A | N/A | N/A |
| Net Cash Flow | $-1,166 | $1,865 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,096 | -983 | N/A | N/A | N/A |
| Free Cash Flow | -1,096 | -983 | 0 | 0 | 0 |